Show simple item record

Synthesis of N‐{N‐[4‐(4‐{ N ‐[ 11 C]methylamino}phenyl)butyryl]‐L‐prolyl}pyrrolidine: A potential radiotracer for prolyl endopeptidase

dc.contributor.authorVan Dort, Marcian E.en_US
dc.contributor.authorKilbourn, Michael R.en_US
dc.contributor.authorMangner, Thomas J.en_US
dc.date.accessioned2012-03-16T15:58:24Z
dc.date.available2012-03-16T15:58:24Z
dc.date.issued1994-05en_US
dc.identifier.citationVan Dort, Marcian E.; Kilbourn, Michael R.; Mangner, Thomas J. (1994). "Synthesis of N‐{N‐[4‐(4‐{ N ‐[ 11 C]methylamino}phenyl)butyryl]‐L‐prolyl}pyrrolidine: A potential radiotracer for prolyl endopeptidase." Journal of Labelled Compounds and Radiopharmaceuticals 34(5): 447-452. <http://hdl.handle.net/2027.42/90277>en_US
dc.identifier.issn0362-4803en_US
dc.identifier.issn1099-1344en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90277
dc.description.abstractThe synthesis of the 4‐[ 11 C]methylamino derivative of N‐{N‐[4‐(4‐Aminophenyl)butyryl]‐L‐prolyl}pyrrolidine (SUAM‐1221), is described as a potential marker for prolyl endopeptidase for in vivo positron emission tomography studies. Direct methylation of the 4‐amino derivative of SUAM‐1221 ( 1 ) with methyl iodide provided a mixture of the 4‐monomethyl ( 2 ) and 4‐dimethylamino ( 3 ) derivatives which were separated by chromatography. Methylation of 1 with [ 11 C]methyl iodide provided the 4‐[ 11 C]methylamino derivative of SUAM‐1221, ([ 11 C] 2 ), in 18–30% decay corrected radiochemical yield after HPLC purification, with a specific activity > 1700 Ci/mmol and a 40 minute synthesis time from end of bombardment.en_US
dc.publisherJohn Wiley & Sons, Ltd.en_US
dc.subject.otherProlyl Endopeptidase Inhibitoren_US
dc.subject.otherPETen_US
dc.subject.otherCarbon‐11en_US
dc.subject.otherSUAM‐1221en_US
dc.titleSynthesis of N‐{N‐[4‐(4‐{ N ‐[ 11 C]methylamino}phenyl)butyryl]‐L‐prolyl}pyrrolidine: A potential radiotracer for prolyl endopeptidaseen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelRadiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Nuclear Medicine, Department of Internal Medicine University of Michigan Medical School, Ann Arbor, Ml 48109‐0552, U.S.A.en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90277/1/2580340507_ftp.pdf
dc.identifier.doi10.1002/jlcr.2580340507en_US
dc.identifier.sourceJournal of Labelled Compounds and Radiopharmaceuticalsen_US
dc.identifier.citedreferenceWilk S. ‐ Life Sci. 33: 2149 ( 1983 ).en_US
dc.identifier.citedreferenceJewett D. M. ‐ Rev. Sci. Instrum. 58: 1964 ( 1987 ).en_US
dc.identifier.citedreferenceCrouzel C., Langstrom B., Pike V. W. and Coenen H. H. ‐ Appl. Radiat. Isot. 38: 601 ( 1987 ).en_US
dc.identifier.citedreferenceStill W. C., Kahn M. and Mitra M. ‐ J. Org. Chem. 43: 2923 ( 1978 ).en_US
dc.identifier.citedreferenceFurukawa S., Ikezawa R., Yoshimoto T., Yamamoto N., Tsuru D., Kojima M., Nishimura M. and Kaneto H. ‐ J. Pharmacobio‐Dyn. 12: 136 ( 1989 ).en_US
dc.identifier.citedreferenceAtack J. R., Suman‐Chauhan N., Dawson G. and Kulagowski J. J. ‐ Eur. J. Pharmacol. 205: 157 ( 1991 ).en_US
dc.identifier.citedreferenceIshiura S. ‐ J. Neurochem. 56: 363 ( 1991 ).en_US
dc.identifier.citedreferenceTerwel D., Markerink M. and Jolles J. ‐ Dementia 3: 108 ( 1992 ).en_US
dc.identifier.citedreferenceFriedman T. C., Orlowski M. and Wilk S. ‐ J. Neurochem. 42: 237 ( 1984 ).en_US
dc.identifier.citedreferenceOrlowski M., Wilk E., Pearce S. and Wilk S. ‐ J. Neurochem. 33: 461 ( 1979 ).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.